Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin

MLA

Klastersky, J., et al. “Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin.” Antimicrobial Agents and Chemotherapy, vol. 7, no. 5, May 1975, pp. 640–45. EBSCOhost, https://doi.org/10.1128/AAC.7.5.640.

APA

Klastersky, J., Hensgens, C., & Debusscher, L. (1975). Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin. Antimicrobial Agents and Chemotherapy, 7(5), 640–645. https://doi.org/10.1128/AAC.7.5.640

Chicago

Klastersky, J., C. Hensgens, and L. Debusscher. 1975. “Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin.” Antimicrobial Agents and Chemotherapy 7 (5): 640–45. doi:10.1128/AAC.7.5.640.